Type 2 diabetes mellitus Trials in Stockholm, Sweden
Conditions / Type 2 diabetes mellitus / Stockholm, Sweden
Type 2 diabetes mellitus is a medical condition with active clinical research programs worldwide.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | TERMINATED | PHASE3 |
| NCT04255433 | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02009527 | Arginase Inhibition in Ischemia-reperfusion Injury | COMPLETED | PHASE1 |
| NCT01676220 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy | COMPLETED | PHASE3 |
| NCT01107886 | Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications | COMPLETED | PHASE4 |
| NCT03675464 | Study of Human Adipose Tissue (LOSHAT) | UNKNOWN | — |
| NCT00975286 | 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine | COMPLETED | PHASE3 |
| NCT06065540 | A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | COMPLETED | PHASE3 |
| NCT03521934 | Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) | TERMINATED | PHASE3 |